FIMECS, Inc. (CSO), Japan

Kanae Gamo is leading overall research as a CSO at FIMECS, Inc. She co-founded FIMECS in 2018 as a spin-out biotech from Takeda Pharmaceutical Co., Ltd. She has expertise in many techniques of molecular biology, genetics, epigenetics and next-generation sequencing in oncology and immunology areas. During her time at Takeda, she increased responsibility of roles across target identification and validation and contributed to multiple programs. In parallel with FIMECS work, she got a Ph.D. at the University of Tsukuba in 2020. She is passionate about leveraging proprietary drug discovery platform, RaPPIDS, to unlock new biological space and accelerate pipeline progression.